Madrigal Pharmaceuticals, Inc. (MDGL)
Market Closed
17 Jul, 20:00
$
553. 48
+7.95
+1.4573%
$
12.58B Market Cap
- P/E Ratio
- Div Yield
528,300 Volume
-19.39 Eps
$ 545.53
Previous Close 
Want to track MDGL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Madrigal Pharmaceuticals, Inc. (MDGL) Statistics
Valuation metrics
Market Cap 12.58B
Enterprise value 12.88B
Trailing P/E (ttm) -43.24
Forward P/E 41.25
PEG ratio -1.48
Price/Sales (ttm) 11.27
Price/Book (mrq) 29.57
Enterprise Value/Revenue 11.37
Enterprise Value/EBITDA -45.81
Overview
Shares outstanding 22.84M
Float 12.49M
Shares short 3.91M
% Held by insiders 0.08%
% Held by institutions 1.05%
Average volume (10 days) 286.52K
Average volume (90 days) 338.7K
Price summary
52-Week low 286.44
52-Week high 615
Beta -1.01
50-Day moving average 524.59
200-Day moving average 500.49
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:35
Last split Date 25 Jul 2016
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.27%
Operating margin -0.28%
Operational effectiveness
Return on assets -0.25%
Return on equity -0.5%
Income Statement
Revenue (ttm) 958.4M
Revenue per share (ttm) 39.01
Quarterly revenue growth (yoy) 2.11%
Gross profit (ttm) 902.25M
EBITDA -298.59M
Net income to common (ttm) -288.28M
Diluted EPS (ttm) -10.66
Quarterly earnings growth (yoy) 2.11%
Balance Sheet
Total cash (mrq) 983.56M
Total cash per share (mrq) 28.17
Total debt (mrq) 347.63M
Total Debt/Equity (mrq) 0.64
Current ratio (mrq) 3.5%
Book value per share (mrq) 18.72
Cash Flow
Cash flow statement -189.55M
Levered free cash flow (LFCF) -115.08M
